drug
design
notabl
challeng
due
viru
abil
mutat
develop
immun
commerci
avail
drug
aim
project
develop
seri
flexim
base
analogu
possess
inher
flexibl
remain
activ
face
bind
site
mutat
also
target
noncanon
highli
conserv
target
nucleocapsid
protein
hiv
nc
compound
predict
comput
studi
function
via
zinc
eject
would
endow
signific
advantag
nonspecif
thu
toxic
zincejector
target
flexim
base
synthes
use
palladiumcatalyz
crosscoupl
techniqu
subsequ
test
nc
result
studi
describ
herein
time
seleyradtk
group
design
synthes
variou
class
flexibl
purin
nucleo
ide
flexim
novel
nucleosid
design
investig
flexibl
nucleobas
could
potenti
affect
receptorligand
recognit
function
addit
flexibl
design
allow
overcom
issu
bind
site
mutat
thu
retain
activ
date
flexim
shown
key
advantag
correspond
purinebas
nucleosid
exampl
distal
guanosin
flexim
flexg
fig
prove
inhibitor
sadenosyllhomocystein
hydrolas
adapt
syn
conform
therebi
place
exocycl
amino
group
mimick
amino
group
adenosin
nucleobas
moreov
guanosin
flexim
triphosph
flexgtp
shown
superior
substrat
human
gdplfucos
pyrophosphorylas
compar
natur
substrat
gtp
like
due
flexim
abil
interact
amino
acid
activ
site
access
gtp
also
allow
flexgtp
retain
activ
essenti
catalyt
residu
need
gtp
bind
mutat
recent
seri
flexim
possess
acycl
sugar
exhibit
broad
spectrum
antivir
activ
coronavirus
flavivirus
filovirus
support
signific
effort
explor
flexim
approach
virus
viru
abil
readili
mutat
develop
antivir
resist
seri
flexim
design
studi
silico
abil
inhibit
viru
nucleocapsid
protein
nc
nc
play
sever
key
role
replic
nonspecif
bind
act
chaperon
protein
partial
protect
viral
nucleic
acid
na
revers
transcript
nc
direct
anneal
cellular
trna
ly
primer
primer
bind
site
thu
initi
synthesi
strong
stop
dna
nc
facilit
two
strand
transfer
requir
strand
synthesi
also
implic
vital
element
vdna
integr
prior
encapsid
nc
discrimin
viral
host
na
select
bind
signal
sequenc
addit
vitro
studi
shown
nc
may
chaperon
dimer
two
copi
viral
genom
rna
rearrang
kiss
complex
extend
duplex
seri
stabil
destabil
event
import
step
prior
encapsid
nc
interact
multipl
highli
conserv
sequenc
genom
essenti
subtyp
nc
repres
power
drug
target
develop
novel
antivir
importantli
thought
highli
resist
mutat
due
multifunct
role
thu
provid
signific
advantag
protein
target
thu
inhibitor
interact
nc
viral
nucleic
acid
could
provid
new
approach
antiretrovir
therapi
purpos
seri
flexim
comput
design
goal
mind
herein
report
synthesi
biolog
result
seri
compound
predict
interact
nc
mani
structur
studi
done
date
nc
guanosin
residu
shown
consist
stack
residu
whether
bound
dna
pbsdna
rna
inher
flexibl
flexim
guanin
analogu
predict
affect
bind
potenti
result
inhibit
base
hypothesi
number
flexim
nucleosid
initi
design
howev
earli
result
show
sugar
moieti
flexim
nucleosid
provid
benefit
flexim
base
result
correspond
flexim
base
analogu
therefor
pursu
sinc
would
signfiicantli
shorten
synthet
rout
thu
flexim
base
test
comput
nmr
structur
nc
complex
small
molecul
inhibitor
fig
end
comput
protocol
establish
refin
group
botta
sever
nc
bind
small
molecul
alreadi
discov
protocol
support
valid
dock
result
flexim
base
nc
reveal
sever
key
advantag
propos
target
compound
dock
conform
flexim
base
fig
within
hydrophob
pocket
locat
correspond
show
excel
structur
overlay
respect
guanin
base
moreov
flexim
base
abl
establish
network
hbond
interact
backbon
atom
key
residu
hydrophob
pocket
ie
fig
highli
compar
establish
guanin
base
fig
addit
adopt
similar
stack
conform
observ
natur
guanin
howev
addit
rotat
bond
allow
pyrimidin
moieti
extend
interact
neighbor
residu
ie
bind
mode
fig
solvent
area
distal
guanin
flexim
base
predict
bind
stronger
proxim
base
notabl
slightli
stronger
guanin
base
tabl
although
score
valu
calcul
fred
dock
program
function
highli
compar
thu
observ
differ
guanin
may
signific
addit
dock
studi
surprisingli
show
bipyrimidin
scaffold
fig
would
also
highli
advantag
although
slightli
lesser
extent
parent
imidazolepyrimidin
scaffold
tabl
thu
target
pursu
well
result
molecular
model
analysi
compound
fig
select
best
start
candid
proof
concept
intend
rout
achiev
set
flexibl
purin
bipyrimidin
base
util
palladiumcatalyz
crosscoupl
pyrimidin
organometal
coupl
partner
imidazol
halogen
coupl
partner
goal
achiev
two
product
one
reaction
organometal
moieti
shown
undergo
homocoupl
crosscoupl
reaction
distal
compound
predict
better
binder
nc
first
goal
instal
organomet
avoid
protect
exocycl
amin
obtain
iodin
intermedi
commerci
avail
iodin
use
hydroiod
acid
scheme
reaction
neutral
filter
precipit
recrystal
ethanol
obtain
sinc
proxim
intermedi
easili
achiev
start
similar
methodolog
appli
obtain
intermedi
use
variou
palladium
catalyst
well
rang
temperatur
none
condit
yield
desir
organostannan
scheme
organoboran
consid
subsequ
suzuki
coupl
scheme
howev
boron
ester
could
gener
condit
crosscoupl
intermedi
could
obtain
palladium
catalysi
harsher
condit
use
achiev
desir
coupl
partner
exocycl
amin
protect
scheme
tm
immun
grignard
lithium
reagent
cleav
easili
mildli
acid
condit
tm
group
ad
sequenti
oppos
simultan
form
situ
lithium
halogen
exchang
use
nbuli
follow
metal
tributyltin
chlorid
final
produc
deprotect
organostannan
character
h
c
nmr
addit
ms
confirm
presenc
product
howev
prove
highli
unstabl
decompos
rapidli
instal
metal
pyrimidin
prove
difficult
literatur
show
organozinc
intermedi
could
gener
situ
imidazol
moieti
subsequ
negishi
coupl
previou
methodolog
abandon
benzyl
bn
protect
group
initi
chosen
bn
robust
mani
condit
organozinc
gener
situ
subsequ
negishi
coupl
scheme
yield
protect
distal
flexim
albeit
poor
yield
moreov
bn
methyl
group
extrem
difficult
deprotect
scheme
hydrogen
use
pdc
presenc
h
room
temperatur
thought
suffici
remov
bn
group
howev
reaction
occur
ultim
achiev
heat
reaction
mixtur
ammonium
format
pdc
etoh
boron
tribromid
bbr
employ
deprotect
methyl
howev
solubl
problem
aros
attempt
demethyl
dcm
therefor
deprotect
methyl
effici
perform
prior
deprotect
bn
scheme
unfortun
molecul
prove
difficult
purifi
via
column
chromatographi
like
due
either
polar
natur
abil
stack
effici
presenc
two
heteroaromat
moieti
multipl
hydrogen
bond
element
bypass
challeng
trityl
protect
group
employ
protect
imidazol
exocycl
amin
pyrimidin
protect
tertbutyloxycarbonyl
boc
scheme
negishi
coupl
use
two
heterocycl
prove
facil
crosscoupl
reaction
proceed
room
temperatur
scheme
trityl
deprotect
accomplish
use
acet
acid
boc
deprotect
requir
trifluoroacet
acid
previous
mention
methyl
protect
flexim
guanin
insolubl
dcm
howev
solubl
etoac
final
deprotect
use
bbr
etoac
success
sinc
ultim
obtain
negishi
coupl
similar
strategi
employ
obtain
analog
bipyrimidin
scheme
unexpectedli
aminelink
compound
produc
instead
compound
subject
aminolysi
convert
chloro
group
exocycl
amin
howev
start
materi
product
recov
scheme
hindsight
presenc
palladium
catalyst
like
induc
buchwaldhartwig
amin
lead
synthesi
absenc
compound
correct
crosscoupl
procedur
could
easili
perform
scheme
pursu
instead
envis
first
bromin
barbitur
acid
pobr
follow
nucleophil
substitut
use
sodium
methoxid
afford
compound
achiev
target
bipyrimidin
still
coupl
first
convert
stannan
interestingli
never
synthes
howev
bipyrimidin
recov
good
yield
scheme
two
strategi
attempt
attain
desir
bipyrimidin
first
remov
methyl
protect
group
follow
chlorin
via
pocl
tri
intermedi
use
crude
insolubl
variou
purif
solvent
tetrachlorin
intermedi
could
isol
crude
reaction
mixtur
difficult
purifi
next
approach
directli
convert
methoxi
group
amin
enzymat
convert
group
eoh
use
adenosin
deaminas
neither
start
materi
product
recov
like
due
harsh
condit
use
sinc
homocoupl
pyrimidin
occur
dimethoxypyrimidin
specul
condit
would
like
produc
homocoupl
product
well
fortuit
prove
true
scheme
unfortun
product
prove
highli
insolubl
imposs
purifi
observ
via
ms
achiev
distal
analogu
prove
challeng
focu
turn
synthes
proxim
analogu
consid
synthesi
compound
facil
straightforward
still
halogen
pyrimidin
produc
bipyrimidin
scheme
howev
similar
purif
solubl
issu
occur
complet
seri
proxim
flexim
guanin
also
pursu
instead
use
still
crosscoupl
techniqu
negishi
method
use
achiev
distal
flexim
guanin
employ
scheme
surprisingli
product
observ
reaction
allow
stir
room
temperatur
poor
yield
found
even
reflux
failur
reaction
specul
due
placement
halogen
electronrich
carbon
posit
pyrimidin
palladium
prefer
react
electrondefici
carbon
oxid
addit
reaction
electronrich
halogen
coupl
partner
palladium
like
occur
led
absenc
desir
coupl
product
henc
organozinc
place
pyrimidin
subsequ
reaction
predict
organozinc
pyrimidin
success
synthes
situ
negishi
crosscoupl
follow
deprotect
trityl
group
accomplish
yield
scheme
regrett
methyl
deprotect
produc
proxim
flexim
guanin
unsuccess
use
bbr
either
ch
cl
etoac
intermedi
insolubl
deprotect
use
catalyt
sulfur
acid
tmscl
acet
anhydrid
also
produc
confirm
ms
hypothesi
explain
phenomenon
tie
silico
result
bardon
et
al
show
thermodynam
stabl
conform
proxim
flexim
base
planar
form
conform
could
promot
stack
base
consequ
allow
solubil
usual
solvent
dimethoxypyrimidin
seri
also
pursu
prove
facil
obtain
addit
protect
step
requir
follow
approach
realiz
seri
dimethoxi
proxim
compound
synthes
use
pyrimidin
organometal
moieti
scheme
deprotect
methyl
group
attempt
howev
result
crude
mixtur
insolubl
thu
purif
possibl
similar
condit
use
synthes
dimethyl
protect
distal
flexim
xanthosin
scheme
scheme
yield
higher
major
structur
differ
substitut
ome
versu
nhboc
compound
hand
h
nmr
experi
perform
nc
flexim
bind
na
bind
site
nc
resid
shift
observ
aromat
region
protein
similar
shown
goudreau
et
al
record
h
nmr
spectra
nc
without
one
equival
molar
ratio
ad
sampl
dissolv
dmsod
aliphat
region
aromat
region
fig
record
signific
chang
nc
signal
detect
studi
necessarili
exclud
nc
binder
prove
interact
weak
thu
undetect
via
nmr
experi
unfortun
none
product
success
purifi
would
dissolv
nmr
solvent
presenc
protein
therefor
nmr
studi
abandon
final
target
compound
sent
nation
cancer
institut
nci
test
dr
eric
freed
disappointingli
none
analogu
exhibit
meaning
antivir
activ
number
flexim
base
success
synthes
via
palladiumcatalys
crosscoupl
studi
albeit
difficulti
anticip
especi
purif
synthet
rout
develop
distal
flexim
base
bypass
classic
tricycl
rout
use
seleyradtk
group
decad
yield
could
improv
would
potenti
use
synthesi
distal
flexim
nucleosid
futur
biolog
howev
molecul
recogn
nc
base
nmr
experi
perform
inact
biolog
result
disappoint
project
provid
better
understand
palladiumcatalys
crosscoupl
strategi
flexim
base
term
choos
optimum
crosscoupl
partner
proven
advantag
project
ongo
group
other
result
publish
becom
avail
chemic
obtain
commerci
sourc
use
without
purif
unless
otherwis
note
anhydr
dmf
ch
oh
dmso
etoh
purchas
fisher
scientif
anhydr
thf
aceton
ch
cl
ch
cn
ether
obtain
use
solvent
purif
system
mbraun
labmast
nmr
solvent
purchas
cambridg
isotop
laboratori
andov
h
c
nmr
spectra
obtain
either
jeol
ecx
mhz
nmr
oper
mhz
respect
bruker
avanc
iii
hd
mhz
nmr
oper
mhz
respect
referenc
intern
tetramethylsilan
tm
ppm
spin
multipl
indic
symbol
singlet
doublet
dd
doublet
doublet
triplet
q
quartet
multiplet
br
broad
reaction
monitor
thinlay
chromatographi
tlc
use
mm
whatman
diamond
silica
gel
precoat
plate
purif
perform
teledyn
isco
combiflash
rf
elut
indic
solvent
system
yield
refer
chromatograph
spectroscop
h
c
nmr
homogen
materi
mass
spectra
record
umbc
mcac
nomin
use
bruker
ii
esiapci
maldi
dual
sourc
apex
r
qe
ftm
john
hopkin
mass
spectrometri
facil
high
resolut
use
vg
analyt
magnet
sector
mass
spectromet
commerci
avail
g
mmol
suspend
ml
wt
hi
h
mixtur
stir
room
temperatur
h
result
sludg
dilut
ml
neutral
ph
use
sat
na
co
precipit
filter
recrystal
etoh
yield
white
solid
g
mmol
mg
mmol
dissolv
n
ml
anhydr
thf
cool
etmgbr
ml
mmol
ad
dropwis
allow
stir
min
tmscl
ml
mmol
ad
allow
stir
min
etmgbr
ml
mmol
ad
dropwis
allow
stir
min
tmscl
ml
mmol
ad
allow
stir
min
nbutyllithium
ml
mmol
ad
dropwis
allow
warm
room
temperatur
stir
h
tributyltin
chlorid
ml
mmol
ad
mixtur
stir
min
reaction
quench
use
ml
nh
cl
solvent
remov
vacuo
crude
materi
extract
ch
cl
ml
wash
brine
ml
organ
layer
dri
mgso
crude
materi
purifi
use
silica
gel
column
chromatographi
hexan
etoac
yield
yellow
oil
mg
mg
mmol
dissolv
n
ml
anhydr
thf
cool
etmgbr
ml
mmol
ad
dropwis
allow
stir
min
zncl
thf
ml
mmol
subsequ
ad
dropwis
stir
min
warm
room
temperatur
stir
h
organozinc
ad
dropwis
mixtur
mg
mmol
pd
pph
mg
mmol
cui
mg
mmol
ml
anhydr
thf
allow
stir
room
temperatur
h
reaction
quench
use
ml
sat
edta
solut
thf
remov
vacuo
crude
materi
extract
ch
cl
ml
wash
brine
ml
organ
layer
dri
mgso
crude
materi
purifi
use
silica
gel
column
chromatographi
hexanesetoac
yield
white
solid
mg
mmol
yield
r
f
etoac
synthet
procedur
relat
scheme
report
mg
mmol
dissolv
ml
trifluoroacet
acid
stir
h
solvent
remov
crude
materi
purifi
use
silica
gel
column
chromatographi
ch
cl
ch
oh
yield
white
solid
mg
mmol
yield
r
f
ch
cl
ch
oh
mg
mmol
dissolv
ml
anhydr
ch
cl
n
cool
bbr
ml
mmol
ad
dropwis
reaction
allow
warm
room
temperatur
stir
h
mixtur
drip
slowli
ml
ice
water
stir
min
solvent
remov
vacuo
crude
materi
purifi
use
silica
gel
column
chromatographi
ch
cl
ch
oh
yield
white
solid
mg
mmol
yield
r
f
ch
cl
ch
oh
g
mmol
suspend
ml
ch
cl
n
ditertbutyl
decarbon
g
mmol
g
mmol
ad
reaction
allow
stir
room
temperatur
h
tlc
show
absenc
start
materi
two
product
solvent
commerci
avail
mg
mmol
dissolv
n
ml
anhydr
thf
cool
etmgbr
ml
mmol
ad
dropwis
allow
stir
min
zncl
thf
ml
mmol
subsequ
ad
dropwis
stir
min
warm
room
temperatur
stir
h
organozinc
ad
dropwis
mixtur
mg
mmol
pd
pph
mg
mmol
cui
mg
mmol
ml
anhydr
thf
allow
stir
room
temperatur
h
reaction
quench
use
ml
sat
edta
solut
thf
remov
vacuo
crude
materi
extract
ch
cl
ml
wash
brine
ml
organ
layer
dri
mgso
crude
materi
purifi
use
silica
gel
column
chromatographi
hexanesetoac
yield
yellow
oil
mg
mmol
yield
r
f
hexanesetoac
mg
mmol
dissolv
ml
acet
acid
stir
h
solvent
remov
crude
materi
purifi
use
silica
gel
column
chromatographi
ch
cl
ch
oh
yield
offwhit
solid
mg
mmol
yield
r
f
ch
cl
ch
oh
mg
mmol
dissolv
ml
anhydr
etoac
n
cool
boron
tribromid
ml
mmol
ad
dropwis
reaction
allow
warm
room
temperatur
stir
h
mixtur
drip
slowli
ml
ice
water
stir
min
solvent
remov
vacuo
crude
materi
purifi
use
silica
gel
column
chromatographi
ch
cl
ch
oh
yield
white
solid
mg
mmol
yield
r
f
ch
cl
ch
oh
synthesi
mg
mmol
dissolv
ml
degass
glass
tube
bi
tributyltin
ml
mmol
ad
follow
pd
pph
cl
mg
mmol
glass
tube
seal
heat
h
tube
cool
open
warm
room
temperatur
crude
content
filter
pad
celit
solvent
remov
crude
materi
purifi
use
silica
gel
column
chromatographi
ch
cl
ch
oh
yield
impur
mixtur
anoth
attempt
purif
silica
gel
column
chromatographi
use
pharmasset
condit
etoacch
mg
mmol
dissolv
n
ml
anhydr
thf
cool
etmgbr
ml
mmol
ad
dropwis
allow
stir
min
tmscl
ml
mmol
ad
allow
stir
min
etmgbr
ml
mmol
ad
dropwis
allow
stir
min
tmscl
ml
mmol
ad
allow
stir
min
etmgbr
ml
mmol
ad
dropwis
allow
stir
min
follow
addit
zncl
thf
ml
mmol
dropwis
stir
min
warm
room
temperatur
stir
h
organozinc
ad
dropwis
mixtur
mg
mmol
pdcl
pph
mg
mmol
cui
mg
mmol
ml
anhydr
thf
allow
stir
reflux
h
reaction
quench
use
ml
sat
edta
solut
thf
remov
vacuo
crude
materi
extract
ch
cl
ml
wash
brine
ml
organ
layer
dri
mgso
crude
materi
purifi
use
silica
gel
column
chromatographi
hexanesetoac
yield
white
solid
mg
mmol
yield
r
f
hexan
etoac
h
nmr
mhz
dmsod
br
br
commerci
avail
barbitur
acid
g
mmol
suspend
ml
anhydr
toluen
n
cool
phosphoru
v
oxybromid
g
mmol
ad
n
ndimethylanilin
ml
mmol
ad
dropwis
mixtur
heat
stir
vigor
h
reaction
cool
room
temperatur
quench
ml
ice
water
mixtur
transfer
separatori
funnel
remain
insolubl
gum
wash
etoac
ml
organ
layer
combin
wash
sat
nahco
ml
brine
ml
organ
layer
dri
mgso
crude
materi
purifi
use
silica
gel
column
chromatographi
hexanesetoac
yield
solid
g
mmol
yield
r
f
hexaneset
ml
mmol
ad
dropwis
mixtur
warm
room
temperatur
stir
h
reaction
quench
use
ml
nh
cl
solvent
remov
crude
materi
extract
ch
cl
ml
wash
brine
ml
organ
layer
dri
mgso
crude
materi
purifi
use
silica
gel
column
chromatographi
hexanesetoac
synthesi
mg
mmol
dissolv
ml
degass
glass
tube
bi
tributyltin
ml
mmol
ad
follow
pd
pph
mg
mmol
glass
tube
seal
heat
h
tube
cool
open
warm
room
temperatur
crude
content
filter
pad
celit
solvent
remov
crude
materi
purifi
use
silica
gel
column
chromatographi
hexan
etoac
yield
white
fluffi
solid
mg
mmol
yield
r
f
hexanesetoac
mg
mmol
mg
mmol
dissolv
ml
degass
dmf
pd
pph
mg
mmol
cui
mg
mmol
csf
mg
mmol
ad
reaction
allow
stir
h
content
cool
filter
celit
solvent
remov
crude
materi
purifi
use
silica
gel
column
chromatographi
ch
cl
ch
oh
yield
contamin
contamin
sampl
recrystal
etoac
follow
ethanol
follow
methanol
final
dmso
obtain
white
solid
mg
mmol
yield
h
nmr
mhz
dmsod
br
mg
mmol
dissolv
n
ml
thf
cool
etmgbr
ml
mmol
ad
dropwis
allow
stir
min
tmscl
ml
mmol
ad
allow
stir
min
etmgbr
ml
mmol
ad
dropwis
allow
stir
min
tmscl
ml
mmol
ad
allow
stir
min
etmgbr
ml
mmol
ad
dropwis
allow
stir
min
follow
addit
zncl
thf
ml
mmol
dropwis
stir
min
warm
room
temperatur
stir
h
organozinc
ad
dropwis
mixtur
mg
mmol
pd
pph
mg
mmol
cui
mg
mmol
ml
thf
allow
stir
room
temperatur
h
reaction
quench
use
ml
sat
edta
solut
thf
remov
vacuo
crude
materi
extract
ch
cl
ml
wash
brine
ml
organ
layer
dri
mgso
crude
materi
purifi
use
silica
gel
column
chromatographi
hexan
etoac
yield
yellow
solid
mg
mmol
yield
r
f
etoac
mg
mmol
dissolv
ml
acet
acid
stir
h
solvent
remov
crude
materi
purifi
use
silica
gel
column
chromatographi
ch
cl
ch
oh
yield
offwhit
solid
mg
mmol
yield
r
f
ch
cl
ch
oh
commerci
avail
mg
mmol
dissolv
n
ml
anhydr
thf
cool
etmgbr
ml
mmol
ad
dropwis
allow
stir
min
zncl
thf
ml
mmol
subsequ
ad
dropwis
stir
min
warm
room
temperatur
stir
h
organozinc
ad
dropwis
mixtur
mg
mmol
pd
pph
mg
mmol
cui
mg
mmol
ml
thf
allow
stir
reflux
h
reaction
quench
use
ml
sat
edta
solut
thf
remov
vacuo
crude
materi
extract
ch
cl
ml
wash
brine
ml
organ
layer
dri
mgso
crude
materi
purifi
use
silica
gel
column
chromatographi
ch
cl
ch
oh
yield
white
solid
mg
mmol
yield
r
f
ch
cl
ch
oh
commerci
avail
mg
mmol
suspend
ml
degass
dmf
n
follow
addit
bi
pinacolato
diboron
mg
mmol
potassium
acet
mg
mmol
pdcl
dppf
mg
mmol
mixtur
heat
stir
h
reaction
cool
transfer
ml
dh
mixtur
extract
etoactoluen
ml
wash
brine
ml
organ
layer
dri
mgso
solvent
remov
vacuo
crude
product
use
without
purif
synthesi
commerci
avail
mg
mmol
crude
mmol
suspend
ml
degass
n
seal
glass
flask
cs
co
g
mmol
pdcl
dppf
mg
mmol
glass
flask
seal
heat
stir
h
flask
chill
open
warm
room
temperatur
crude
content
filter
pad
celit
solvent
evapor
vacuo
crude
materi
purifi
use
silica
gel
column
chromatographi
hexanesetoac
yield
white
solid
mg
mmol
yield
r
f
hexan
etoac
mg
mmol
dissolv
n
ml
thf
cool
etmgbr
ml
mmol
ad
dropwis
allow
stir
min
zncl
thf
ml
mmol
subsequ
ad
dropwis
stir
min
warm
room
temperatur
stir
h
organozinc
ad
dropwis
mixtur
mg
mmol
pd
pph
mg
mmol
cui
mg
mmol
ml
thf
allow
stir
room
temperatur
h
reaction
quench
use
ml
sat
edta
solut
thf
remov
vacuo
crude
materi
extract
ch
cl
ml
wash
brine
ml
organ
layer
dri
mgso
crude
materi
purifi
use
silica
gel
column
chromatographi
hexanesetoac
yield
white
solid
mg
mmol
yield
r
f
hexan
etoac
mg
mmol
dissolv
ml
acet
acid
stir
h
solvent
remov
crude
materi
purifi
use
silica
gel
column
chromatographi
ch
cl
ch
oh
yield
white
solid
mg
mmol
yield
r
f
ch
cl
ch
oh
molecular
model
studi
perform
describ
previou
studi
briefli
nmr
structur
nc
complex
small
molecul
inhibitor
use
rigid
receptor
molecular
dock
simul
carri
fred
dock
program
openey
version
ligand
conform
analysi
perform
omega
openey
nc
code
region
pcr
amplifi
use
ccagctaccatacatatgcagaaaggc
ndei
site
underlin
ggccggatcctccctaactaattagcct
gtctctc
bamhi
stop
codon
underlin
express
vector
novagen
madison
wi
doubli
digest
ndei
bamhi
treat
calf
intestin
alkalin
phosphat
pcr
product
purifi
phenolextract
ethanolprecipit
doubli
digest
ndei
bamhi
insert
vector
ligat
use
phage
dna
ligas
five
hour
transform
compet
dna
transform
sequenc
found
ident
nc
code
sequenc
clone
design
overexpress
nc
protein
sequenc
q
k
g
n
f
r
n
q
r
k
v
k
c
f
n
c
g
k
e
g
h
k
n
c
r
p
r
k
k
g
c
w
k
c
g
k
e
g
h
q
k
c
e
r
q
n
two
zinc
knuckl
underlin
ionspray
mass
spectrometri
confirm
mass
apoprotein
da
calcul
da
da
calcul
da
znbound
protein
protein
express
nc
escherichia
coli
transform
plyse
purif
scheme
recombin
nc
adapt
ji
et
al
mchenri
cultur
media
supplement
ampicillin
chloramphenicol
starter
cultur
ml
zb
inocul
singl
coloni
grown
overnight
starter
cultur
ad
l
supplement
mm
zncl
grown
absorb
nm
induct
mm
iptg
three
hour
cell
harvest
centrifug
resuspend
ml
lysi
buffer
mm
trishcl
ph
vv
glycerol
nacl
mm
zncl
mm
dithiothreitol
mm
edta
store
lyse
cell
cell
thaw
icewat
ml
mm
pmsf
phenylmethylsulfonyl
fluorid
ml
mg
ml
pepstatin
ml
wv
sodium
deoxychol
ad
cell
sonic
five
burst
second
reduc
viscos
nucleic
acid
precipit
ad
wv
polyethyleneimin
ph
dropwis
final
concentr
stir
minut
centrifug
g
minut
supernat
collect
ml
filter
pore
size
load
mlminut
onto
ml
qsepharos
ml
spsepharos
column
pharmacia
connect
seri
previous
equilibr
ml
buffer
mm
trishcl
ph
glycerol
nacl
mm
zncl
mm
bme
wash
ml
buffer
qsepharos
column
detach
spsepharos
column
wash
column
volum
buffer
ten
column
volum
linear
gradient
buffer
b
mm
trishcl
ph
glycerol
nacl
mm
zncl
mm
bme
appli
elut
nc
protein
protein
fraction
pool
ml
load
mlminut
onto
ml
sephadex
column
pharmacia
preequilibr
two
volum
buffer
c
mm
trishcl
ph
glycerol
nacl
mm
mm
bme
nc
protein
elut
ml
fraction
pool
ml
concentr
dialysi
nmr
buffer
see
nmr
buffer
mm
trishcl
ph
mm
kcl
mm
nacl
mm
mgcl
deoxygen
sparg
argon
minut
filtersteril
pore
size
protein
sampl
dialyz
use
ad
nmr
buffer
five
six
time
total
volum
ml
buffer
protein
sampl
lyophil
eas
storag
protein
sampl
made
load
mm
nmr
tube
take
blank
h
spectrum
test
compound
titrat
protein
sampl
ratio
compoundprotein
could
establish
data
h
nmr
signal
assign
collect
sampl
temperatur
bruker
dmx
mhz
h
nmr
bruker
avanc
iii
hd
mhz
nmr
spectromet
author
conflict
declar
